Tuesday, November 13, 2007

diabetes and liver disease

In the article “Hepatobiliary Disease in Type 2 Diabetes Mellitus” written by Keith G. Tolman, MD; Vivian Fonseca, MD; Meng H. Tan, MD; and Anthony Dalpiaz, PharmD published here we learn that:“Diabetes mellitus is the fifth leading cause of death in the United States; 17 million people are affected. Liver disease is one of the leading causes of death in persons with type 2 diabetes. The standardized mortality rate for death from liver disease is greater than that for cardiovascular disease. The spectrum of liver disease in type 2 diabetes ranges from nonalcoholic fatty liver disease to cirrhosis and hepatocellular carcinoma. The incidence of hepatitis C and acute liver failure is also increased. Nonalcoholic fatty liver disease is now considered part of the metabolic syndrome, and, with alcohol and hepatitis C, is the most common cause of chronic liver disease in the United States.”
Badly controlled blood sugar increases the risk of nonalcoholic fatty liver disease, which can lead to scarring of the liver (nonalcoholic cirrhosis). Other medical conditions related to diabetes — such as high cholesterol also increase the risk of nonalcoholic fatty liver disease. In addition, some medications used to treat these related conditions, such as cholesterol-lowering drugs, may cause liver damage. Liver Combo is a natural supplement with Milk Thistle (200 mg), Dandelion (200 mg), Licorice (50 mg), Nettle Leaf (50 mg) and Schizandra (50mg) in order to protect and take care of your liver.

No comments: